MiFID II Research Fees – Most are going to take to P&L – See the Latest List

 

Below is a the latest list of who’s planning on doing what with the research fees. More and more firms are confirming that they’ll be taking the fees to P&L with the RPA route becoming increasing unpopular within the UK. This is not a surprise given the knock on ramifications of taking the RPA approach.

The OCREUS Group have their own independant views, opinions and advisory paper on this matter which some firms have used as part of their thought process.

Number of firms have still yet to decide or have declined to disclose their approach at this time.

Take to P&L RPA Undecided
Allianz Global Investors Amundi Ashmore
Aviva Investors BNP Parisbas BNY Mellon
Axa Investment Management Carmignac Candriam
Baille Gifford Deka GAM
Barlings Fidelity Interational Legal & General Investment Management
Blackrock Man Group Lyxor
BlueBay Asset Management Natixis Global Asset Management
Brewin Dolphin Nordea
Brooks Macdonald Old Mutual Global Investors
Canada Life Pictet
Charles Stanley
Deutche Asset Management
Evenlode
Equitile
Flossbach von Storch
Franklin Templeton
Goldman Sachs Asset Management
Hernes
HBSC Global Asset Management
Insight Investment
Invesco
Janus Henderson
JO Hambro
JP Morgan Asset Management
Jupiter
Kempen Capital Management
M&G Investment
Majedie Asset Management
Morgan Stanley
MN Investments Partners
Newton Investment Management
Northern Trust Asset Management
Pimco
Rathbones
RBC
Robeco
Royal London
Russell Investment
Schroders
Seven Investment
Standard Life Aberdeen
Stwewart Investors
SVM
T Rowe Price
Troy Asset Management
Twenty Four Asset Management
UBS
Unigestion
Union Investmenet
Vanguard
Woodford Investmenet Management
Data at of 11th October 2017
Source – FT research